Kowalik C G¹, Daily A¹, Delpe S¹, Kaufman M R¹, Dmochowski R¹, Reynolds W S¹
1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
Female, Overactive Bladder, Questionnaire, Voiding Dysfunction

Drangsholt S¹, Slawin J¹, Brucker B M¹
1. New York University
Neuromodulation, Overactive Bladder, Outcomes Research Methods

Smith G¹, Bolderson J¹, Lane S², Trochez R¹
1. Liverpool Women's Hospital NHS Trust, 2. University of Liverpool
Female, Overactive Bladder, Urgency Urinary Incontinence

Rovner E¹, Tu L², De Wachter S G³, Versi E⁴, Dmochowski R⁵
1. Medical University of South Carolina, USA, 2. Sherbrooke University Hospital, Canada, 3. University of Antwerp, Belgium, 4. Rutgers Robert Wood Johnson Medical School, NJ, USA, 5. Vanderbilt University, USA
Overactive Bladder, New Devices, Clinical Trial, Female, Sensory Dysfunction

Diez-Itza I¹, Martín-Martínez A², Uranga S¹, Avila M¹, Lekuona A¹, García-Hernández J A²
1. Hospital Universitario Donostia. San Sebastian. Spain, 2. Complejo Hospitalario Universitario Insular Materno Infantil. Las Palmas de Gran Canaria. Spain
Overactive Bladder, Pelvic Organ Prolapse, Anatomy

Matsuo T¹, Miyata Y¹, Araki K¹, Nakamura Y¹, Sagara Y¹, Ohba K¹, Sakai H¹
1. Nagasaki University Hospital
Overactive Bladder, Prospective Study, Male, Gerontology

McCammon K¹, Gousse A², Gruenenfelder J³, Hale D⁴, Orejudos A⁵, Patel A⁶, Kohan A⁷
1. Eastern Virginia Medical School, Norfolk, VA, USA, 2. Memorial Hospital Miramar, Miramar, FL, USA, 3. Orange County Urology Associates, Laguna Hills, CA, USA, 4. Urogynecology Associates, PC, Indianapolis, IN, USA, 5. Allergan plc, Irvine, CA, USA, 6. Allergan plc, Marlow, UK, 7. Advanced Urology Centers of New York, Bethpage, NY, USA
Incontinence, Overactive Bladder, Urgency/Frequency

Waterschoot M¹, Uvin P¹, Everaerts W², Raskin Y¹, Voets T³, Van Oudenhove L⁴, Van der Aa F², van den Heijkant M⁵
1. Department of Urology, University of Leuven, 2. Department of development and regeneration, organ systems, Experimental Urology, University of Leuven, 3. Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, University of Leuven & VIB Center for Brain & Disease Research, Leuven, 4. Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical & Experimental Medicine, University of Leuven, Belgium & University Psychiatric Centre KU Leuven, Leuven, 5. Department of Urology, Department of pediatric Urology, University of KU Leuven
Overactive Bladder, Detrusor Overactivity, Prospective Study, Urodynamics Techniques, Questionnaire

Amiri M¹, Murgas S², Michel M C³
1. University of Duisburg-Essen, 2. Apogepha, 3. Johannes Gutenberg University
Overactive Bladder, Outcomes Research Methods, Prospective Study, Pharmacology, Incontinence

Nguyen A¹, Tam J², Du C¹, Wang Q¹, Hung M², Kim J²
1. Stony Brook University School of Medicine, 2. Stony Brook University Medical Center Department of Urology
Overactive Bladder, Detrusor Overactivity, Urgency/Frequency, Voiding Dysfunction , Retrospective Study

Herrewegh A¹, Vrijens D¹, Kruimel J², Leue C³, van Koeveringe G¹
1. Maastricht University Medical Center+, Department of Urology, Pelvic Care Center, 2. Maastricht University Medical Center+, Division of Gastroenterology-Hepatology, Department of Internal Medicine, 3. Maastricht University Medical Center+, Department of Psychiatry and Medical Psychology
Overactive Bladder, Questionnaire, Terminology, Quality of Life (QoL), Pathophysiology

Michel M C¹, Murgas S², Oelke M³, Schneider T⁴
1. Johannes Gutenberg University, 2. Apogepha, 3. St Antonius Hospital, 4. Praxis-Klinik Rhein-Ruhr
Overactive Bladder, Outcomes Research Methods, Clinical Trial, Pharmacology